Application of an artificial intelligence-based tool in [18F]FDG PET/CT for the assessment of bone marrow involvement in multiple myelomaChristos Sachpekidis, Antonia Dimitrakopoulou‐Strauss, Hartmut Goldschmidt et al.|European Journal of Nuclear Medicine and Molecular Imaging|2023Cited by 35
Validation of novel low-dose CT methods for quantifying bone marrow in the appendicular skeleton of patients with multiple myeloma: initial results from the [18F]FDG PET/CT sub-study of the Phase 3 GMMG-HD7 TrialChristos Sachpekidis, Antonia Dimitrakopoulou‐Strauss, Marina Hajiyianni et al.|European Journal of Nuclear Medicine and Molecular Imaging|2025Cited by 4
P-011 Hematopoietic reconstitution and infections after anti-BCMA CAR T-cell therapy in relapsed/ refractory multiple myeloma are associated with pre-CAR-T bridging therapiesJan Frenking, Marc S. Raab, Joseph Kauer et al.|Clinical Lymphoma Myeloma & Leukemia|2023Cited by 0
Structured whole-body MRI highlights clinically relevant disease pattern changes in relapsed/refractory multiple myelomaMartin Grözinger, Lukas John, M Schlanke et al.|Leukemia|2025Cited by 0
Interpreting [18F]FDG-avid fractures after induction therapy in multiple myeloma: insights from the PET/CT sub-study of the Phase 3 GMMG-HD7 trialChristos Sachpekidis, H Goldschmidt, Marina Hajiyianni et al.|European Journal of Nuclear Medicine and Molecular Imaging|2026Cited by 0